| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.0006 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |